BrorsONilsonOGSayerG. Influence of pH and buffer type on drug binding in human serum. Clin Pharmacokinet1984; 9 (suppl 1): 85–6.
2.
WittingJGiesenWFJanssenLHM. The effect of albumin conformation on the binding of warfarin to human serum albumin. J Biologic Chem1980; 255: 3032–7.
3.
HaHRVozehSFollathF. Measurement of free lidocaine serum concentration by equilibrium dialysis and ultrafiltration technique: The influence of pH and heparin. Clin Pharmacokinet1984; 9 (suppl 1): 96.
4.
HenryJAMitchellN. Effect of pH on human plasma protein binding of a series of B-adrenoceptor antagonists. Br J Clin Pharmacol1981; 11: 119p–20p.
5.
ShawLMAltmanRThompsonBC. Effect of several variables on the in vitro binding of disopyramide to serum protein. Clin Pharmacokinet1984; 9 (suppl 1): 98–9.
6.
PonganisKVStanskiDR. Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis. Clin Pharmacokinet1984; 9 (suppl 1): 95.
7.
BowdleTAPatelILevyRH. Valproic acid dosage and plasma protein binding and clearance. Clin Pharmacol Ther1980; 28: 486–92.
8.
FurstDTozerTNMelmonKL. Salicylate clearance, the result of protein binding and metabolism. Clin Pharmacol Ther1979; 26: 380.
9.
ChenBHTaylorEHPappasAA. Total and free disopyramide by fluorescence polarization immunoassay and relationship between free fraction and alpha-1 acid glycoprotein. Clin Chim Acta1987; 163: 75–80.